Anti-phospholipid antibodies as a risk factor for renal injury in patients with systemic lupus erythematosus: a comprehensive analysis

BackgroundAlthough the existence of antiphospholipid antibodies (aPL) has been extensively documented as a risk factor for thrombocytopenia, hemolytic anemia, and recurrent miscarriage, their contribution to renal damage in the context of the systemic lupus erythematosus (SLE) is yet to be defined....

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Hui Guan, Chengzi Tian, Lefeng Chen, Wenjing Wang, Lihuan Zhang, Mingcheng Huang, Xiaofei Wang, Duo Chen
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2026-02-01
Ráidu:	Frontiers in Immunology
Fáttát:	anti-phospholipid antibodies anti-phospholipid syndrome lupus anticoagulant renal injury systemic lupus erythematosus
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1734274/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!